Mealey's (January 15, 2019, 2:45 PM EST) -- WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals’ ruling that an Indian tribe’s sovereign immunity cannot shield a drug company from inter partes review (IPR) of patents should be...
Tribe, Drugmaker Ask Justices To Overturn Bar On Sovereign Immunity IPR Protection
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login